See the DrugPatentWatch profile for cosentyx

Cosentyx, also known as secukinumab, is a medication used to treat a variety of conditions including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug called a monoclonal antibody, which works by targeting and blocking a specific protein in the body that causes inflammation [1].

While Cosentyx is generally considered safe and effective for the treatment of these conditions, long-term use of the medication may mask underlying joint issues. This is because Cosentyx works by reducing inflammation, which can alleviate the symptoms of joint problems such as pain and swelling [2]. However, this does not mean that the underlying joint damage is not still occurring.

In a study of patients with psoriatic arthritis, it was found that those who were treated with Cosentyx had similar levels of joint damage progression as those who were not treated with the medication [3]. This suggests that while Cosentyx may be effective at managing the symptoms of joint problems, it may not prevent the underlying joint damage from occurring.

It is important for patients who are taking Cosentyx to continue to have regular check-ups with their healthcare provider to monitor their joint health and to discuss any concerns they may have. Additionally, patients should be aware of the potential for joint damage to occur even if they are not experiencing symptoms [2].

In summary, long-term use of Cosentyx may mask underlying joint issues by reducing inflammation and alleviating symptoms, but it does not prevent the underlying joint damage from occurring. Patients should continue to have regular check-ups with their healthcare provider to monitor their joint health.

Sources:

* [1] "Cosentyx (secukinumab)". Drugs.com. <https://www.drugs.com/cosentyx.html>
* [2] "Secukinumab: Side Effects, Dosage, Uses, and More". Healthline. <https://www.healthline.com/health/secukinumab-cosentyx>
* [3] "Secukinumab in Active Psoriatic Arthritis". New England Journal of Medicine. <https://www.nejm.org/doi/full/10.1056/NEJMoa1513108>
* DrugPatentWatch.com - Not used in the answer but it's a good source for drug patent information.